Intrinsic Value of S&P & Nasdaq Contact Us

ARYx Therapeutics, Inc. ARYX OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
33/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ARYX

ARYx Therapeutics, Inc. (ARYX) has a market capitalization of $16.73K and trades at $0.00. The 52-week range is 0.000001-0.0005.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-1.21.

The stock has a beta of -7.55, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range0.000001-0.0005
Volume2K
Avg Volume (30D)1.1K
Market Cap$16.73K
Beta (1Y)-7.55
Company
IPO Date2007-11-07
Employees56
CEOPaul Goddard
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS0433871094
CUSIP043387109
Income (Latest Year)
EBITDA$-30.06M
Operating Income$-31.24M
Net Income$-33.17M
EPS$-1.21
EPS Diluted$-1.21
Shares Outstanding$27.44M
Balance Sheet (Latest Year)
Total Assets$12.41M
Current Assets$8.81M
Cash & ST Investments$7.76M
Total Liabilities$15.32M
Total Debt$11.7M
Net Debt$4.29M
Total Equity$-2.92M
Debt / Equity-4.01
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message